The short answer
BI-RADS 3 is report language that needs context. In breast imaging reports, it is the federal mammography category "probably benign," meaning a high chance the finding is not cancer. Short-interval follow-up is commonly discussed. This page explains the plain-language meaning, limits, likely next questions, and why your care team must interpret it with the rest of your results.
BI-RADS 3 has a specific meaning in breast imaging reports.
The phrase alone is not the whole diagnosis or treatment plan.
The next step depends on the full report, prior tests, symptoms, and your cancer history.
Ask what the finding changes, what remains uncertain, and when you will review the plan.
Choose how you want to read this
The whole article, with every detail and caution.
This page is for anyone whose mammogram report says BI-RADS 3. It explains what "probably benign" means and what to ask.
What the category says
BI-RADS stands for Breast Imaging Reporting and Data System. It is a scale from 0 to 6 that radiologists use to sum up a breast imaging result.
Under the federal mammography rule (21 CFR 900.12), every mammogram report must carry a named assessment. For category 3 the name is "Probably Benign." The rule says this means the finding has a high probability of being benign.
So a 3 is not a cancer diagnosis. It is also not, on its own, a biopsy recommendation. Ask your radiologist what follow-up they advise and why.
Timing of your result
The same federal rule sets deadlines for telling you the result.
- Facilities must give you a plain-language summary within 30 calendar days of the exam.
- If the assessment is "Suspicious" or "Highly Suggestive of Malignancy," the deadline is 7 calendar days.
A BI-RADS 3 is not in the 7-day group. If you have not heard back and are worried, call the facility.
Why callbacks are common
The National Cancer Institute (NCI) reports that about 10 percent of women are called back for more testing after a screening mammogram, but only about 0.5 percent of those screened have cancer. About half of women screened every year for ten years have at least one false-positive result.
Most findings that lead to extra testing are not cancer. The "probably benign" label is one way a report says that.
A 3 is different from a 0
NCI and the federal rule treat these as separate categories. A 0 means more imaging is needed before the radiologist can give a final category. If your report says 3 and you are unsure whether all the imaging was done, ask.
The density sentence is separate
Your report also has a breast density statement. Federal rules require one of two plain-language notices. One says your breast tissue is not dense. The other says your tissue is dense and that, in some people with dense tissue, other imaging tests in addition to a mammogram may help find cancers.
Density is a separate finding from your BI-RADS number.
Ask these before you leave
- Was this a screening study, or did it include extra views or an ultrasound?
- What exactly is the finding?
- Were older mammograms compared, and if not, can they be sent?
- What follow-up is advised, on what date, and is it scheduled?
- What change on a later test would lead to a biopsy?
- Will the follow-up be billed as a diagnostic study, and what will it cost me?
- Does my personal or family history change the plan?
If you notice a new lump, skin change or nipple discharge, call your care team right away rather than waiting for a scheduled visit.
Related pages
See Imaging Tests, Pathology Reports, and Getting a Second Opinion.
Sources

Common questions
What does BI-RADS 3 mean?
Federal mammography rules call this category "probably benign," a high probability that the finding is benign. Short-interval follow-up is commonly discussed.
Does it mean cancer?
It is not the same as a cancer diagnosis and usually is not the same as a biopsy recommendation.
What should I ask next?
A practical next question is to ask what follow-up schedule is recommended, whether older images were compared, and what change would trigger biopsy.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Look up related pathology, imaging, biomarker, and treatment-response language.
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-10-02 what this meansLast updated: 2026-10-02Next planned review: 2027-07-20
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
Knowledge check
0 of 3 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
